Skip to content
Screener

Grid Dynamics Holdings, Inc. GDYN Healthcare and Pharma — Revenue

Other product segments

Technology, Media and Telecom
$30.76M+30.3%
Retail
$29.57M-6.2%
Finance
$24.45M-2.3%
CPG/Manufacturing
$9.76M-9.4%

Similar metrics at other companies

Paysign logo
PAYSPharma Industry — Revenue
$14.65M+88.9%
GoodRx Holdings, Inc. logo
GDRXPharma Direct revenue — Revenue
$61.63M+76.2%
VAT
VATEHealthcare — Revenue
$41.5M-20.2%
Tutor Perini logo
TPCHealthcare facilities — Revenue
$339.62M+32.0%
Weis Markets logo
WMKPharmacy — Revenue
$167.19M+5.4%
Icahn Enterprises logo
IEPPharma — Revenue
$17M-50.0%

Other financials

Income statement

See full
Revenue$104.1M+3.7%
Gross profit$36.2M-2.1%
Operating income-$3.7M-80.7%
Net income-$1.5M-151%
EPS (diluted)-$0.02-167%

Balance sheet

See full
Cash & equivalents$327.5M+0.5%
Total debt$17.4M+50.4%
Total equity$530.1M+2.5%
Total assets$605.0M+2.4%

Cash flow

See full
Operating cash flow$8.4M-10.3%
CapEx$4.0M+18.6%
Free cash flow$4.4M-26.3%

Valuation

See full
Market cap$614.94M-5.1%
Enterprise value$304.89M-6.5%
P/E116.4×+78.3×
P/S1.5×-0.2×

Profitability

See full
Gross margin34.1%-2.7pp
Operating margin-1.3%-0.5pp
Net margin1.3%-1.7pp
FCF margin5.7%-0.9pp

Returns & leverage

See full
Return on equity1%-1.4pp
Debt / equity0.0×
Current ratio7.9×+0.6×

Where this comes from

Reported directly by Grid Dynamics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Grid Dynamics Holdings, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:40 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001743725-26-000014
VerticalThree Months Ended March 31, 2026 / (in thousands)Three Months Ended March 31, 2025 / (in thousands)
Technology, Media and Telecom$30,759$23,602
Retail29,56931,521
Finance24,45425,028
CPG/Manufacturing(1)9,76210,771
Healthcare and Pharma2,1542,405
Other7,4027,088
Revenues$104,100$100,415

Item 1. Financial Statements (Unaudited)

FAQ

What is Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue?
Grid Dynamics Holdings, Inc. (GDYN) reported healthcare and pharma — revenue of $2.15M in Q1 2026.
How has Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue changed year-over-year?
Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue decreased by 10.4% year-over-year, from $2.41M to $2.15M.
What is the long-term trend for Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue?
Over 3 years (2022 to 2025), Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue has grown at a 9.7% compound annual growth rate (CAGR), from $7.71M to $10.18M.
What does healthcare and pharma — revenue mean?
This metric represents the total gross revenue generated specifically from digital transformation and technology consulting services provided to clients within the healthcare and pharmaceutical industry vertical. It reflects the company's ability to capture market share and deliver specialized technical solutions to organizations operating in this highly regulated sector. Tracking this revenue stream helps investors assess the company's diversification strategy and its success in penetrating the life sciences market.

Ask your AI about Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude